The phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of the rapamycin (mTOR) pathway is a key therapeutic target of cancer cells, as its components are observed to be activated in most cancers including GC. The gene discussed is AKT1; the disease is gastric cancer.